Dale A. Sander, CFO and Chief Corporate Deve. Officer at Humacyte, Inc. (HUMA), bought 20,000 shares at $1.53 ($31K) on 2025-04-10, disclosed to the SEC on 2025-04-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| HUMA | BUY | 2022-12-19 | $52K | — | Filing → |
| HUMA | BUY | 2022-05-18 | $9K | — | Filing → |